ConductScience.org, home

Paper21320065

In-silico ADME models: a general assessment of their utility in drug discovery applications.

Gleeson MP and 2 others. Curr Top Med Chem, 2011. Cited by 112 papers, by iCite.

Cite this record

ConductScience Library. In-silico ADME models: a general assessment of their utility in drug discovery applications. Papers, record 21320065. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21320065

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In-silico ADME models: a general assessment of their utility in drug discovery applications.
PubMed
Journal
Curr Top Med Chem
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
112
iCite
Relative citation ratio, by iCite
3.94
iCite
Revised in PubMed
2019-09-07
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gleeson MPM Paul
2Hersey AAnne
3Hannongbua SSupa

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug DiscoveryMajor topic
Models, BiologicalMajor topic
Pharmaceutical PreparationsMajor topic
PharmacokineticsMajor topic
Animals
Humans
Metabolic Clearance Rate
Predictive Value of Tests
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.

PMIDTitleJournalYearIn PapersSource
40575559Isolation, structural elucidation, and integrated biological and computational evaluation of antidiabetic labdane diterpenes from Curcuma zedoaria rhizomes.RSC Adv2025https://conductscience.org/library/papers/40575559PubMed
39726044Comprehensive benchmarking of computational tools for predicting toxicokinetic and physicochemical properties of chemicals.J Cheminform2024https://conductscience.org/library/papers/39726044PubMed
38833492A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations.PLoS One2024https://conductscience.org/library/papers/38833492PubMed
38817777Molecular docking of curcumin and curcuminoids as human Zn+ dependent histone deacetylase (HDAC) enzyme inhibitors.In Silico Pharmacol2024https://conductscience.org/library/papers/38817777PubMed
38596366Phytochemical identification and in silico elucidation of interactions of bioactive compounds from Citrullus lanatus with androgen receptor towards prostate cancer treatment.In Silico Pharmacol2024https://conductscience.org/library/papers/38596366PubMed
38470555In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer.Mol Divers2024https://conductscience.org/library/papers/38470555PubMed
38434818Thiazolotriazoles As Anti-infectives: Design, Synthesis, Biological Evaluation and In Silico Studies.ACS Omega2024https://conductscience.org/library/papers/38434818PubMed
37919954Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer.J Enzyme Inhib Med Chem2023https://conductscience.org/library/papers/37919954PubMed
37908659Challenges in natural product-based drug discovery assisted with in silico-based methods.RSC Adv2023https://conductscience.org/library/papers/37908659PubMed
37893530Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment.Medicina (Kaunas)2023https://conductscience.org/library/papers/37893530PubMed
37575679
In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies.
In Silico Pharmacol2023https://conductscience.org/library/papers/37575679PubMed
37513210Cytotoxicity and Genotoxicity Evaluation of Zanthoxylum rhoifolium Lam and In Silico Studies of Its Alkaloids.Molecules2023https://conductscience.org/library/papers/37513210PubMed
37298535New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods.Int J Mol Sci2023https://conductscience.org/library/papers/37298535PubMed
37255832In silico docking based screening of constituents from Persian shallot as modulators of human glucokinase.J Diabetes Metab Disord2023https://conductscience.org/library/papers/37255832PubMed
36721524Synthesis of [60]Fullerene Hybrids Endowed with Steroids and Monosaccharides: Theoretical Underpinning as Promising anti-SARS-CoV-2 Agents.European J Org Chem2023https://conductscience.org/library/papers/36721524PubMed
36676057Alternative Methods as Tools for Obesity Research: In Vitro and In Silico Approaches.Life (Basel)2022https://conductscience.org/library/papers/36676057PubMed
36316339Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions.Sci Rep2022https://conductscience.org/library/papers/36316339PubMed
36109764Synthesis, biological evaluation and in-silico ADME studies of novel series of thiazolidin-2,4-dione derivatives as antimicrobial, antioxidant and anticancer agents.BMC Chem2022https://conductscience.org/library/papers/36109764PubMed
35479426Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition.RSC Adv2021https://conductscience.org/library/papers/35479426PubMed
35209197Phytochemical and In Silico ADME/Tox Analysis of Eruca sativa Extract with Antioxidant, Antibacterial and Anticancer Potential against Caco-2 and HCT-116 Colorectal Carcinoma Cell Lines.Molecules2022https://conductscience.org/library/papers/35209197PubMed

See all 47 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21320065

GET https://conductscience.org/api/papers/v1/21320065/cited_by?page=2